Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 28, Issue 2, 2007, Pages 78-82

  Arrieta, José R ^a   Galgano, Alejandro S ^b   Sakano, Eulalia ^c   Fonseca, Ximena ^d   Amábile Cuevas, Carlos F ^e   Hernández Oliva, Gerardo ^f   Vivar, Raul ^f   González, Gerardo ^f   Torres, Arturo ^f  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b Policlinico Bancario   (Argentina)

^c Instituto Penido Burnier   (Brazil)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e Fundacion LUSARA   (Mexico)

^f Bayer Company   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; MOXIFLOXACIN;

ABDOMINAL PAIN; ACUTE SINUSITIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIARRHEA; DIGESTIVE SYSTEM DISEASE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENLARGED ABDOMEN; ERADICATION THERAPY; FEMALE; HUMAN; LIVER FUNCTION TEST; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROLOGIC DISEASE; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SOUTH AMERICA; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUINOLINES; SINUSITIS;

EID: 33847759477     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2006.06.016     Document Type: Article

References (15)

1. Gwaltney Jr. J.M. Acute community-acquired sinusitis. Clin Infect Dis 23 (1996) 1209-1223
2. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 123 (2000) 5-31
3. Blondeau J.M. A review of the comparative in vitro activities of 12 antimicrobial agents, with a focus on five new "respiratory quinolones". J Antimicrob Chemother 43 Suppl B (1999) 1-11
4. Scheld W.M. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 9 (2003) 1-9
5. Siegert R., Gehanno P., Nikolaidis P., et al. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respir Med 94 (2000) 337-344
6. Burke T., Villanueva C., Mariano Jr. H., et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. Clin Ther 21 (1999) 1664-1677
7. Baz M.N., Jannetti W., Villanueva C., et al. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis. Todays Ther Trends 17 (1999) 303-319
8. Klossek J.M., and Arvis P. Moxifloxacin versus trovafloxacin in the treatment of acute bacterial maxillary sinusitis: a multinational, double-blind, randomized study. 11th European Congress of Clinical Microbiology and Infectious Diseases, Istanbul, Turkey (2001)
9. Rakkar S., Roberts K., Towe B.F., et al. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. Int J Clin Pract 55 (2001) 309-315
10. Calva J.J., Niebla-Pérez A., Rodríguez-Lemoine V., et al. Antibiotic usage and antibiotic resistance in Latin America. In: Amábile-Cuevas C.F. (Ed). Antibiotic resistance: from molecular basics to therapeutic options (1996), RG Landes/Chapman & Hall, Austin, TX 73-97
11. Hickner J.M., Bartlett J.G., Besser R.E., et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 134 (2001) 498-505
12. Sader H.S., Gales A.C., Granacher T.D., et al. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Braz J Infect Dis 4 (2000) 245-254
13. Critchley I.A., Thornsberry C., Piazza G., et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98. Clin Microbiol Infect 6 (2000) 178-184
14. Gehanno P., Darantière S., Dubreuil C., et al. A prospective multicenter study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery in the sinus. J Antimicrob Chemother 49 (2002) 821-826
15. Dinis P.B., Monteiro M.C., Martins M.L., et al. Sinus tissue concentration of moxifloxacin after a single oral dose. Ann Otol Rhinol Laryngol 113 (2004) 142-146